• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIATORR® TIPS ENDOPROSTHESIS; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS Back to Search Results
Catalog Number PT106275
Device Problems Occlusion Within Device (1423); Activation, Positioning or Separation Problem (2906)
Patient Problems Edema (1820); Renal Failure (2041)
Event Date 07/13/2015
Event Type  Injury  
Event Description
It was reported the physician implanted a gore viatorr tips endoprosthesis in a transjugular intrahepatic portosystemic shunt (tips) procedure.Three weeks following the implant, the patient returned with recurrent large volume ascites and renal failure.Stent occlusion was confirmed.The physician reported finding soft clot in the hepatic vein end of the stent, and firm clot with tissue ingrowth at the other end.A review of the implant procedure images confirmed the likelihood the device was deployed too high into the parenchymal tract, so that the uncovered portion of the stent was in the tract by a few millimeters.The fellow who deployed the stent later confirmed that they suspected the stent may have been pulled too far back during deployment.Additionally, the stent was only post-dilated to 6mm, as the patient had a history of encephalopathy.A revision procedure was performed in which a second viatorr device was implanted with no adverse effects.
 
Manufacturer Narrative
The investigation is currently ongoing.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank fields indicate that the information was not provided, was deemed unavailable or was not applicable.
 
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIATORR® TIPS ENDOPROSTHESIS
Type of Device
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4939925
MDR Text Key6036622
Report Number3007284313-2015-00080
Device Sequence Number1
Product Code MIR
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P040027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial
Report Date 08/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2015
Device Catalogue NumberPT106275
Device Lot Number10743602
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/16/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-